MedTrace Logo

Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery

NCT02608489 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2016-10-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is determine whether 3% diquafosol and 0.1% sodium hyaluronate are effective and safe in the treatment of patients with dry eye after cataract surgery.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

Diquafosol (Diquas)

Diquafosol group used diquafosol 6 times a day during study period.

DRUG

Sodium Hyaluronate (Hyalein)

Hyaluronate group used sodium hyaluronate 6 times a day during study period.

Sponsors & Collaborators

  • Soonchunhyang University Hospital

    lead OTHER

Principal Investigators

  • Jin Kwon Chung, MD · Soonchunhyang University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02608489 on ClinicalTrials.gov